Search

Search results

Current filters: English, Hepatitis C, Harm reduction and substance use, Research summary

22 search results

What is the impact of opioid agonist therapy on hepatitis C testing and treatment for people who inject drugs?

From Prevention in Focus - Spring 2021
2021, CATIE
Research summary - Webpage

From the front lines: Adapting programs in response to COVID-19

From Prevention in Focus - Fall 2020
2020, CATIE
Research summary - Webpage

Improved health when treatment for both hepatitis C and opioid use disorder are offered

2020, CATIE
Research summary - Webpage

Hepatitis C treatment in harm reduction programs for people who use drugs

From Prevention in Focus - Spring 2020
2020, CATIE
Research summary - Webpage

Can intravenous ketamine and mindfulness therapy break cocaine dependency?

2019, CATIE
Research summary - Webpage

Supervised Inhalation Site at ARCHES

2019, CATIE
Research summary - Webpage

Overdoses and smoking are taking the lives of people with HIV who have been cured of hepatitis C

2019, CATIE
Research summary - Webpage

Party and play in Canada: What is its impact on gay men’s health?

From Prevention in Focus - Spring 2019
2019, CATIE
Research summary - Webpage

Opioid agonist therapy: Does it have a role to play in helping to prevent hepatitis C and HIV?

From Prevention in Focus - Spring 2019
2019, CATIE
Research summary - Webpage

Harm reduction in action: Supervised consumption services and overdose prevention sites

From Prevention in Focus - Fall 2018
2018, CATIE
Research summary - Webpage